Health Trials

Complement 3 Glomerulopathy

2

Review clinical trials related to Complement 3 Glomerulopathy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain

This study aims to characterize the patient profiles and the clinical experience of iptacopan treatment in adult patients with C3G treated through an early access program (EAP) in Spain.

Participants needed: 35
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Novartis PharmaceuticalsUpdated: Jul 13, 2026
Eligibility criteria

Adult patients (≥18 years). [+2]

Read more
Status: Not yet recruiting

A Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain

This study aims to characterize the patient profiles and the clinical experience of iptacopan treatment in adult patients with C3G treated through an early access program (EAP) in Spain.

Participants needed: 35
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Novartis PharmaceuticalsUpdated: Jun 30, 2026
Eligibility criteria

Adult patients (≥18 years). [+2]

Read more